Cyred Eq Kit
Product Images NDC 50102-254

6 FDA label images from Afaxys Pharma, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cyred Eq (NDC 50102-254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Deso Ethi Fig1)

Figure 1. Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Deso Ethi Fig1)
A bar chart showing mortality rates (number of deaths per 100,000 woman-years) by age group and smoking status. The categories include ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers) across four age groups: 15-24, 25-34, 35-44, and 45 and older. Mortality rates increase with age, highest among ever-users who are smokers in the 45 and older group.*
FDA Label Image

Fig2 (Deso Ethi Fig2)

Fig2 (Deso Ethi Fig2)
A forest plot showing effect estimates with confidence intervals for multiple women’s health studies from 2002 to 2017. Each study is labeled by name and year, with separate results for 'Ever Use' or 'Current Use'. The horizontal axis displays effect estimates ranging from -1.5 to 2.0, centered around 1.0.*
FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg Pouch Label)

Package Label-principal Display Panel (0.15 mg/0.03 mg Pouch Label)
An instructional diagram for Cyred EQ (Desogestrel and Ethinyl Estradiol) tablets, showing a 4-week pill regimen organized by day of the week (Sunday to Saturday). Each week has a row of circles representing daily pills with arrows indicating the order to take them, starting at the top left. Weeks 1 to 3 pills are white to off-white, while Week 4 pills are green and labeled as inactive.*
FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg Blister Carton)

Package Label-principal Display Panel (0.15 mg/0.03 mg Blister Carton)
Packaging label for Cyred EQ (Desogestrel and Ethinyl Estradiol Tablets USP) 0.15 mg/0.03 mg by Afaxys Pharma, LLC. The label identifies the product as a kit containing 1 blister card of 28 tablets, with instructions to take one tablet daily. The label includes the NDC 50102-254-21 and mentions the manufacturer and product origin.*
FDA Label Image

Deso Ethi Fig5

Deso Ethi Fig5
Packaging label for Cyred EQ (Desogestrel and Ethinyl Estradiol Tablets USP) 0.15 mg / 0.03 mg kit by Afaxys Pharma, LLC. The label includes dosage form as tablets, specifies 3 pouches each containing 28 tablets, and lists both the manufacturer Afaxys Pharma in Charleston, SC, USA, and the manufacturing site Aurobindo Pharma Limited in India. The label shows the NDC 50102-254.*
FDA Label Image

Chemical Structure (Deso Ethi Str)

Chemical Structure (Deso Ethi Str)
Chemical structures of desogestrel and ethinyl estradiol, the active ingredients in Cyred EQ. The diagram depicts the molecular arrangements for each hormone, including characteristic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.